Department of Radiology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
Neurosurgery. 2012 Dec;71(2 Suppl Operative):ons253-9; discussion ons259. doi: 10.1227/NEU.0b013e3182647a97.
Although endovascular technique and related devices continue to improve, recanalization of embolized aneurysm remains a pitfall of this approach. The problem of how to treat the recanalized aneurysm needs to be addressed.
To determine the outcomes of patients undergoing repeat embolization for recanalized intracranial aneurysms and to evaluate the impact of stent implantation on subsequent recanalization.
Between September 2001 and September 2011, we performed endovascular retreatment in 162 patients with a total of 197 recanalized intracranial aneurysms. Stent implantation was performed in 68 aneurysms during the retreatment. Clinical and morphological outcomes were assessed at 6 months or more after repeat embolization.
Procedure-related complications, including asymptomatic thromboembolism, occurred with 15 aneurysms (7.6%) without permanent neurological sequelae. Follow-up imaging of 172 aneurysms documented stable occlusion in 96 of the lesions (55.8%), minor recanalization in 17 (9.9%), and major recanalization in 59 (34.3%) during the mean follow-up period of 26.0 ± 18.0 months. In multiple logistic regression analysis, stent implantation was shown to reduce the major recanalization rate at 6 months after retreatment (odds ratio: 0.161; 95% confidence interval:, 0.038-0.670; P = .012) and thereafter (odds ratio: 0.226; 95% confidence interval: 0.088-0.581; P = .002).
Stent implantation, as well as compact coil packing, at the time of repeat embolization seems beneficial in reducing rates of further recanalization.
尽管血管内技术和相关设备不断改进,但栓塞动脉瘤的再通仍是该方法的一个难题。如何处理再通的动脉瘤是需要解决的问题。
确定因颅内动脉瘤再通而行重复栓塞治疗的患者的结局,并评估支架植入对随后再通的影响。
2001 年 9 月至 2011 年 9 月,我们对 162 例共 197 个颅内再通动脉瘤患者进行了血管内再治疗。在再治疗过程中,68 个动脉瘤行支架植入术。在重复栓塞后 6 个月或更长时间评估临床和形态学结局。
15 个动脉瘤(7.6%)出现与操作相关的并发症,包括无症状性血栓栓塞,但无永久性神经后遗症。对 172 个动脉瘤的随访影像学检查显示,在平均 26.0±18.0 个月的随访期间,96 个病变稳定闭塞(55.8%),17 个轻微再通(9.9%),59 个明显再通(34.3%)。在多变量逻辑回归分析中,支架植入术可降低再治疗后 6 个月时的主要再通率(比值比:0.161;95%置信区间:0.038-0.670;P =.012)和此后的主要再通率(比值比:0.226;95%置信区间:0.088-0.581;P =.002)。
在重复栓塞时进行支架植入术和紧密线圈填塞似乎有助于降低再通率。